295 related articles for article (PubMed ID: 29573050)
1. MRI for solitary pulmonary nodule and mass assessment: Current state of the art.
Ohno Y; Kauczor HU; Hatabu H; Seo JB; van Beek EJR;
J Magn Reson Imaging; 2018 Jun; 47(6):1437-1458. PubMed ID: 29573050
[TBL] [Abstract][Full Text] [Related]
2. New applications of magnetic resonance imaging for thoracic oncology.
Ohno Y
Semin Respir Crit Care Med; 2014 Feb; 35(1):27-40. PubMed ID: 24481757
[TBL] [Abstract][Full Text] [Related]
3. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
Ohno Y; Kishida Y; Seki S; Yui M; Miyazaki M; Koyama H; Yoshikawa T
J Magn Reson Imaging; 2018 Apr; 47(4):1013-1021. PubMed ID: 28799280
[TBL] [Abstract][Full Text] [Related]
4. Can MRI contribute to pulmonary nodule analysis?
Koo CW; Lu A; Takahashi EA; Simmons CL; Geske JR; Wigle D; Peikert T
J Magn Reson Imaging; 2019 Jun; 49(7):e256-e264. PubMed ID: 30575193
[TBL] [Abstract][Full Text] [Related]
5. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.
Divisi D; Barone M; Zaccagna G; Crisci R
Ann Med; 2017 Nov; 49(7):626-635. PubMed ID: 28590774
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
8. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
9. FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.
Groheux D; Quere G; Blanc E; Lemarignier C; Vercellino L; de Margerie-Mellon C; Merlet P; Querellou S
Diagn Interv Imaging; 2016 Oct; 97(10):1003-1017. PubMed ID: 27567555
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
Ohno Y; Koyama H; Lee HY; Yoshikawa T; Sugimura K
J Thorac Imaging; 2016 Jul; 31(4):215-27. PubMed ID: 27075745
[TBL] [Abstract][Full Text] [Related]
12. Solitary pulmonary nodule: Comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET/CT.
Ohno Y; Fujisawa Y; Yui M; Takenaka D; Koyama H; Sugihara N; Yoshikawa T
Eur J Radiol; 2019 Jun; 115():22-30. PubMed ID: 31084755
[TBL] [Abstract][Full Text] [Related]
13. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
Spadafora M; Evangelista L; Gridelli C; Cuocolo A
Eur J Radiol; 2017 May; 90():188-191. PubMed ID: 28583632
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and management of pulmonary nodules: state-of-the-art and future perspectives.
Sayyouh M; Vummidi DR; Kazerooni EA
Expert Opin Med Diagn; 2013 Nov; 7(6):629-44. PubMed ID: 24175679
[TBL] [Abstract][Full Text] [Related]
15. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm.
Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R
Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626
[TBL] [Abstract][Full Text] [Related]
16. Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?
Juergens KU; Weckesser M; Stegger L; Franzius C; Beetz M; Schober O; Heindel W; Wormanns D
Eur Radiol; 2006 May; 16(5):1131-7. PubMed ID: 16450084
[TBL] [Abstract][Full Text] [Related]
17. Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review.
Hochhegger B; Zanon M; Altmayer S; Pacini GS; Balbinot F; Francisco MZ; Dalla Costa R; Watte G; Santos MK; Barros MC; Penha D; Irion K; Marchiori E
Lung; 2018 Dec; 196(6):633-642. PubMed ID: 30302536
[TBL] [Abstract][Full Text] [Related]
18. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Aquino SL; Fischman AJ
Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
[TBL] [Abstract][Full Text] [Related]
19. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
[TBL] [Abstract][Full Text] [Related]
20. Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules.
Cha MJ; Lee KS; Kim HS; Lee SW; Jeong CJ; Kim EY; Lee HY
Expert Rev Respir Med; 2016; 10(3):261-78. PubMed ID: 26751340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
